Press release
Animal Genetics Market to Reach USD 14.5 Bn by 2034, Growing at 7.8% CAGR
IntroductionThe global agriculture and livestock industry is undergoing a transformation, with animal genetics playing a crucial role in improving productivity, disease resistance, and sustainability. Animal genetics focuses on the selective breeding and genetic engineering of livestock and companion animals to enhance desirable traits such as milk yield, meat quality, fertility, and resistance to disease.
The growing demand for high-quality animal protein, advances in genomics, and increased investment in sustainable livestock production are fueling market growth. By 2024, the animal genetics market size is estimated at USD 6.8 billion and is projected to reach USD 14.5 billion by 2034, expanding at a CAGR of 7.8%.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72378
Market Overview
Key highlights of the global animal genetics market:
• Market Size 2024: USD 6.8 billion
• Forecast 2034: USD 14.5 billion
• CAGR (2025-2034): ~7.8%
• Key Drivers: Rising global demand for animal-derived protein, adoption of advanced reproductive technologies, growing awareness of animal health, and increasing R&D investments in genomics.
• Challenges: Ethical concerns, high cost of genetic services, regulatory barriers, and limited adoption in low-income economies.
• Leading Players: Genus plc, Neogen Corporation, CRV Holding, Hendrix Genetics, Topigs Norsvin, Zoetis, Alta Genetics, Animal Genetics Inc., EW Group, and Semex Alliance.
The market is innovation-driven, with a strong focus on genomic selection, artificial insemination, and embryo transfer technologies to improve breeding outcomes and animal productivity.
Segmentation Analysis
By Offering
• Genetic Products
o Live Animals (Poultry, Swine, Cattle, Dogs, Horses, Others)
o Semen
o Embryos
• Genetic Testing Services
• Genetic Materials & Genomic Tools
By Animal Type
• Poultry
• Cattle
• Swine
• Canine
• Equine
• Others (Sheep, Goats, etc.)
By Technology
• Artificial Insemination
• Embryo Transfer
• In-Vitro Fertilization (IVF)
• Genomic Selection
• Cloning
By Application
• Meat Production
• Dairy Production
• Companion Animals (Pets, Equines)
• Research & Development
By End User
• Animal Genetic Companies
• Veterinary Hospitals & Clinics
• Research Institutes & Universities
• Livestock Farmers & Breeding Organizations
Summary:
The poultry and cattle segments dominate, supported by rising demand for meat, milk, and dairy products. Artificial insemination is the most widely used technology, while genomic selection is emerging rapidly as precision breeding gains traction.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72378/animal-genetics-market
Regional Analysis
North America
• Largest market share due to advanced animal breeding technologies, well-established livestock industry, and significant investment in genomic research.
• The U.S. leads in both livestock productivity and pet genetics.
Europe
• Strong adoption in countries like Germany, the Netherlands, and France, supported by strict regulations ensuring animal welfare and food quality.
• Focus on sustainable and disease-resistant breeding programs.
Asia-Pacific
• Expected to post the fastest CAGR through 2034, driven by growing demand for animal protein, expanding middle-class consumption, and government programs supporting livestock productivity.
• China and India dominate meat and dairy demand, while Australia is strong in cattle genetics.
Middle East & Africa
• Growing adoption in livestock-heavy economies, especially in beef and dairy production.
• Investments in genetic technologies are rising, though adoption remains uneven.
Latin America
• Brazil and Mexico are major contributors, with robust cattle and poultry industries adopting advanced genetics for export-driven production.
Summary:
North America and Europe lead today, but Asia-Pacific is set to dominate future growth due to rising protein consumption and expanding livestock production systems.
Market Dynamics
Key Growth Drivers
• Rising global demand for meat, milk, and animal-derived products.
• Technological advancements in genomics, AI, and reproductive biology.
• Expansion of companion animal genetics for pets and equines.
• Government initiatives supporting food security and livestock sustainability.
• Growing consumer preference for disease-free and high-quality animal products.
Key Challenges
• Ethical concerns around cloning and genetic modification.
• High cost of advanced genetic technologies and services.
• Regulatory hurdles in genetic engineering and animal welfare.
• Limited awareness and adoption in developing regions.
Latest Trends
• Increasing adoption of genomic selection for precision breeding.
• Expansion of pet DNA testing kits and companion animal genetics.
• Integration of AI and big data to predict genetic traits.
• Use of CRISPR and advanced gene editing to accelerate breeding outcomes.
• Strategic collaborations between genetic companies and research institutes.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72378
Competitor Analysis
Major Players
• Genus plc - Leader in cattle and swine genetics.
• Neogen Corporation - Strong in genomic testing and diagnostics.
• CRV Holding B.V. - Specializes in cattle genetics.
• Hendrix Genetics - Global player in poultry, swine, and aquaculture genetics.
• Topigs Norsvin - Leader in swine genetics.
• Zoetis - Strong portfolio in livestock genetic testing and services.
• Alta Genetics - Focused on cattle breeding and genomic tools.
• Animal Genetics Inc. - Provides genetic testing services for livestock and pets.
• EW Group - A global conglomerate in animal breeding and genetics.
• Semex Alliance - Canadian cooperative specializing in cattle genetics.
Summary:
Competition centers around genomic innovation, global breeding networks, and customer accessibility. While Genus plc and Hendrix Genetics dominate, regional players are expanding in niche markets, particularly in Asia and Latin America.
Conclusion
The animal genetics market is on a strong growth trajectory, expanding from USD 6.8 billion in 2024 to USD 14.5 billion by 2034, at a CAGR of 7.8%.
Key Takeaways:
• Poultry and cattle genetics dominate the market due to rising demand for meat and dairy.
• Artificial insemination remains the most common technique, while genomic selection is a game-changer.
• North America and Europe dominate, but Asia-Pacific is the fastest-growing region.
• Technological advances, sustainability goals, and consumer demand for high-quality protein will shape the market.
This report is also available in the following languages : Japanese (動物遺伝子市場), Korean (동물 유전학 시장), Chinese (动物遗传学市场), French (Marché de la génétique animale), German (Markt für Tiergenetik), and Italian (Mercato della genetica animale), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72378
Our More Reports:
Gene Therapy in Ophthalmology Market
https://exactitudeconsultancy.com/reports/72308/gene-therapy-in-ophthalmology-market
Tonometers Market
https://exactitudeconsultancy.com/reports/72306/tonometers-market
Ophthalmoscopes Market
https://exactitudeconsultancy.com/reports/72304/ophthalmoscopes-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Animal Genetics Market to Reach USD 14.5 Bn by 2034, Growing at 7.8% CAGR here
News-ID: 4198057 • Views: …
More Releases from Exactitude Consultancy

Astaxanthin Market Forecasted to Reach USD 1.4 Billion by 2034
As consumers increasingly prioritize health, wellness, and preventive care, natural antioxidants have gained remarkable importance in global markets. Among them, astaxanthin-a reddish pigment belonging to the carotenoid family-has emerged as one of the most powerful. Known for its potent antioxidant, anti-inflammatory, and anti-aging properties, astaxanthin is widely used in dietary supplements, cosmetics, aquaculture, and pharmaceuticals.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72369
Its unique molecular structure makes it significantly…

RNAi Drug Delivery Market Forecasted to Reach USD 18 Billion by 2034
The pharmaceutical industry is undergoing a transformative era with the rise of advanced therapies that target diseases at the molecular level. Among the most groundbreaking innovations is RNA interference (RNAi), a biological process that silences specific genes responsible for disease progression. RNAi-based drugs harness this mechanism to deliver highly targeted treatments for conditions ranging from rare genetic disorders to cancer and infectious diseases.
Download Full PDF Sample Copy of Market Report…

Influenza Vaccine Market to Reach USD 13.5 Bn by 2034, Growing at 6.5% CAGR
Introduction
Influenza, commonly known as the flu, continues to be a major global public health concern, causing millions of severe cases and hundreds of thousands of deaths annually. Vaccination remains the most effective preventive measure, significantly reducing the burden of seasonal outbreaks and pandemic threats.
The global influenza vaccine market has expanded considerably, driven by heightened awareness, government immunization programs, and rapid advancements in vaccine technologies, such as cell-based and recombinant…

Medical Isotope Production Market to Reach USD 16.2 Bn by 2034, at 10.9% CAGR
Introduction
Medical isotopes have become an indispensable part of modern healthcare, particularly in diagnostic imaging, cancer treatment, and research applications. They are critical in nuclear medicine for procedures such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and targeted radiotherapy. With rising cases of cancer and cardiovascular diseases worldwide, the demand for reliable isotope supply is increasing sharply.
Technological innovations, global collaborations, and the expansion of nuclear medicine are pushing…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…